{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:41:58Z","timestamp":1792683718818,"version":"4.5.0"},"reference-count":405,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":370,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ymthe.2025.04.026","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T11:12:45Z","timestamp":1745233965000},"page":"3485-3527","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Histone deacetylases and their inhibitors in kidney diseases"],"prefix":"10.1016","volume":"33","author":[{"given":"Yue","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tie-Ning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-Hui","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5566-2341","authenticated-orcid":false,"given":"Yue","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.04.026_bib1","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/s41588-022-01097-w","article-title":"Epigenomic and transcriptomic analyses define core cell types, genes and targetable mechanisms for kidney disease","volume":"54","author":"Liu","year":"2022","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2025.04.026_bib2","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1007\/s00018-019-03098-1","article-title":"Dysregulation of histone deacetylases in carcinogenesis and tumor progression: a possible link to apoptosis and autophagy","volume":"76","author":"Patra","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ymthe.2025.04.026_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/cells11243951","article-title":"HDAC6 Inhibition Alleviates Ischemia- and Cisplatin-Induced Acute Kidney Injury by Promoting Autophagy","volume":"11","author":"Shi","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ymthe.2025.04.026_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.986405","article-title":"Molecular mechanisms of histone deacetylases and inhibitors in renal fibrosis progression","volume":"9","author":"Wang","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ymthe.2025.04.026_bib5","doi-asserted-by":"crossref","first-page":"1419685","DOI":"10.3389\/fimmu.2024.1419685","article-title":"The role of HDAC3 in inflammation: mechanisms and therapeutic implications","volume":"15","author":"Watson","year":"2024","journal-title":"Front. immunol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib6","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41581-023-00694-0","article-title":"Regulated cell death pathways in kidney disease","volume":"19","author":"Sanz","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib7","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s41581-020-0309-2","article-title":"Autophagy in kidney homeostasis and disease","volume":"16","author":"Tang","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22115589","article-title":"Kidney Inflammation, Injury and Regeneration 2020","volume":"22","author":"Baer","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2025.04.026_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22010408","article-title":"Fibrosis in Chronic Kidney Disease: Pathogenesis and Consequences","volume":"22","author":"Panizo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2025.04.026_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241814019","article-title":"Pathway from Acute Kidney Injury to Chronic Kidney Disease: Molecules Involved in Renal Fibrosis","volume":"24","author":"Niculae","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2025.04.026_bib11","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.kint.2024.01.010","article-title":"Critical Role of histone deacetylase 3 in the regulation of kidney inflammation and fibrosis","volume":"105","author":"Wang","year":"2024","journal-title":"Kidney Int."},{"key":"10.1016\/j.ymthe.2025.04.026_bib12","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1111\/bph.16299","article-title":"Histone deacetylase-mediated silencing of PSTPIP2 expression contributes to aristolochic acid nephropathy-induced PANoptosis","volume":"181","author":"Xu","year":"2024","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib13","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1002\/ptr.8059","article-title":"Berberine ameliorates contrast-induced acute kidney injury by regulating HDAC4-FoxO3a axis-induced autophagy: In vivo and in vitro","volume":"38","author":"Zuo","year":"2024","journal-title":"Phytother. Res."},{"key":"10.1016\/j.ymthe.2025.04.026_bib14","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s12672-024-01018-9","article-title":"Elevated histone deacetylase 10 expression promotes the progression of clear cell renal cell carcinoma by Notch-1-PTEN signaling axis","volume":"15","author":"Zheng","year":"2024","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1042\/CS20210470","article-title":"The HDAC2\/SP1\/miR-205 feedback loop contributes to tubular epithelial cell extracellular matrix production in diabetic kidney disease","volume":"136","author":"Zheng","year":"2022","journal-title":"Clin. Sci."},{"key":"10.1016\/j.ymthe.2025.04.026_bib16","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20191538","article-title":"2-Methylquinazoline derivative 23BB as a highly selective histone deacetylase 6 inhibitor alleviated cisplatin-induced acute kidney injury","volume":"40","author":"Hao","year":"2020","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.ymthe.2025.04.026_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-24851-w","article-title":"Valproic acid attenuates cellular senescence in diabetic kidney disease through the inhibition of complement C5a receptors","volume":"12","author":"Coughlan","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2025.04.026_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-15162-6","article-title":"Trichostatin A ameliorates renal tubulointerstitial fibrosis through modulation of the JNK-dependent Notch-2 signaling pathway","volume":"7","author":"Tung","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2025.04.026_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2020.152867","article-title":"Inactivation of BRM\/SMARCA2 sensitizes clear cell renal cell carcinoma to histone deacetylase complex inhibitors","volume":"216","author":"Fang","year":"2020","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.ymthe.2025.04.026_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106950","article-title":"Protein acetylation and related potential therapeutic strategies in kidney disease","volume":"197","author":"Li","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ymthe.2025.04.026_bib21","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1042\/bj20021321","article-title":"Histone deacetylases (HDACs): characterization of the classical HDAC family","volume":"370","author":"de Ruijter","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymthe.2025.04.026_bib22","article-title":"Physiological roles of class I HDAC complex and histone demethylase","volume":"2011","author":"Hayakawa","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228828","article-title":"Structure-Based Inhibitor Discovery of Class I Histone Deacetylases (HDACs)","volume":"21","author":"Luo","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2025.04.026_bib24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1089\/ars.2014.5915","article-title":"Class I HDACs Affect DNA Replication, Repair, and Chromatin Structure: Implications for Cancer Therapy","volume":"23","author":"Stengel","year":"2015","journal-title":"Antioxid. Redox Sign."},{"key":"10.1016\/j.ymthe.2025.04.026_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1216548","article-title":"Histone deacetylase 6's function in viral infection, innate immunity, and disease: latest advances","volume":"14","author":"Qu","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib26","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.bbrc.2019.12.048","article-title":"Histone deacetylase 10 knockout activates chaperone-mediated autophagy and accelerates the decomposition of its substrate","volume":"523","author":"Obayashi","year":"2020","journal-title":"Biochem. Bioph Res. Co."},{"key":"10.1016\/j.ymthe.2025.04.026_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115521","article-title":"Research on the progress of Traditional Chinese medicine components and preparations on histone deacetylase inhibitors - Like effects in the course of disease treatment","volume":"296","author":"Wei","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib28","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41580-018-0081-3","article-title":"Functions and mechanisms of non-histone protein acetylation","volume":"20","author":"Narita","year":"2019","journal-title":"Nat. Rev. Mol. Cell Bio."},{"key":"10.1016\/j.ymthe.2025.04.026_bib29","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1074\/mcp.O114.046565","article-title":"Post-translational modifications regulate class IIa histone deacetylase (HDAC) function in health and disease","volume":"14","author":"Mathias","year":"2015","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.ymthe.2025.04.026_bib30","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2217\/epi.15.106","article-title":"Regulation of class IIa HDAC activities: it is not only matter of subcellular localization","volume":"8","author":"Di Giorgio","year":"2016","journal-title":"Epigenomics"},{"key":"10.1016\/j.ymthe.2025.04.026_bib31","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1111\/febs.15895","article-title":"HDAC11: a multifaceted histone deacetylase with proficient fatty deacylase activity and its roles in physiological processes","volume":"289","author":"Nunez-Alvarez","year":"2022","journal-title":"FEBS J."},{"key":"10.1016\/j.ymthe.2025.04.026_bib32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.sbi.2019.01.004","article-title":"Structure, mechanism, and inhibition of the zinc-dependent histone deacetylases","volume":"59","author":"Porter","year":"2019","journal-title":"Curr. Opin. Struc. Biol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib33","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41580-021-00441-y","article-title":"Modulation of cellular processes by histone and non-histone protein acetylation","volume":"23","author":"Shvedunova","year":"2022","journal-title":"Nat. Rev. Mol. Cell Bio."},{"key":"10.1016\/j.ymthe.2025.04.026_bib34","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1126\/science.1175371","article-title":"Lysine acetylation targets protein complexes and co-regulates major cellular functions","volume":"325","author":"Choudhary","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2025.04.026_bib35","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/nrm3931","article-title":"50 years of protein acetylation: from gene regulation to epigenetics, metabolism and beyond","volume":"16","author":"Verdin","year":"2015","journal-title":"Nat. Rev. Mol. Cell Bio."},{"key":"10.1016\/j.ymthe.2025.04.026_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119504","article-title":"Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy","volume":"277","author":"Ramaiah","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.ymthe.2025.04.026_bib37","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.gene.2005.09.010","article-title":"Acetylation and deacetylation of non-histone proteins","volume":"363","author":"Glozak","year":"2005","journal-title":"Gene"},{"key":"10.1016\/j.ymthe.2025.04.026_bib38","doi-asserted-by":"crossref","first-page":"9110","DOI":"10.1007\/s12035-024-04115-6","article-title":"HAT and HDAC: Enzyme with Contradictory Action in Neurodegenerative Diseases","volume":"61","author":"Singh","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib39","article-title":"Physical and functional HAT\/HDAC interplay regulates protein acetylation balance","volume":"2011","author":"Peserico","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib40","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.cytogfr.2012.08.002","article-title":"The HAT\/HDAC interplay: multilevel control of STAT signaling","volume":"23","author":"Icardi","year":"2012","journal-title":"Cyto. Growth F R."},{"key":"10.1016\/j.ymthe.2025.04.026_bib41","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0092-8674(00)80521-8","article-title":"Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain","volume":"90","author":"Gu","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2025.04.026_bib42","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.biocel.2008.08.027","article-title":"Acetylation of non-histone proteins modulates cellular signalling at multiple levels","volume":"41","author":"Spange","year":"2009","journal-title":"Int. J. Biochem. Cell B."},{"key":"10.1016\/j.ymthe.2025.04.026_bib43","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.tplants.2023.06.006","article-title":"Multifaceted functions of histone deacetylases in stress response","volume":"28","author":"Cui","year":"2023","journal-title":"Trends Plant Sci."},{"key":"10.1016\/j.ymthe.2025.04.026_bib44","doi-asserted-by":"crossref","first-page":"4962","DOI":"10.1038\/s41467-024-49370-2","article-title":"Acetylation of histones and non-histone proteins is not a mere consequence of ongoing transcription","volume":"15","author":"Liebner","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.04.026_bib45","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/jcp.30502","article-title":"Regulation of autophagy by protein methylation and acetylation in cancer","volume":"237","author":"Jeon","year":"2022","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib46","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00018-020-03599-4","article-title":"Regulation of histone deacetylase activities and functions by phosphorylation and its physiological relevance","volume":"78","author":"Bahl","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ymthe.2025.04.026_bib47","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/1-4020-5466-1_9","article-title":"Reversible acetylation of non histone proteins: role in cellular function and disease","volume":"41","author":"Batta","year":"2007","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.ymthe.2025.04.026_bib48","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1002\/jcp.25669","article-title":"SirT3 and p53 Deacetylation in Aging and Cancer","volume":"232","author":"Chen","year":"2017","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib49","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1161\/HYPERTENSIONAHA.121.18620","article-title":"Quantitative Phosphoproteomics of the Angiotensin AT(2)-Receptor Signaling Network Identifies HDAC1 (Histone-Deacetylase-1) and p53 as Mediators of Antiproliferation and Apoptosis","volume":"79","author":"Peluso","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/j.ymthe.2025.04.026_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.106","article-title":"Acetylation of HDAC1 and degradation of SIRT1 form a positive feedback loop to regulate p53 acetylation during heat-shock stress","volume":"6","author":"Yang","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ymthe.2025.04.026_bib51","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/14728222.2021.1860016","article-title":"Non-histone substrates of histone deacetylases as potential therapeutic targets in epilepsy","volume":"25","author":"Kumar","year":"2021","journal-title":"Expert Opin. Ther. Tar."},{"key":"10.1016\/j.ymthe.2025.04.026_bib52","article-title":"HIPK2 phosphorylates HDAC3 for NF-kappaB acetylation to ameliorate colitis-associated colorectal carcinoma and sepsis","volume":"118","author":"Zhang","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.04.026_bib53","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1126\/science.1062374","article-title":"Duration of nuclear NF-kappaB action regulated by reversible acetylation","volume":"293","author":"Chen","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2025.04.026_bib54","doi-asserted-by":"crossref","first-page":"E2592","DOI":"10.1073\/pnas.1300113110","article-title":"Histone deacetylase 10 promotes autophagy-mediated cell survival","volume":"110","author":"Oehme","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.04.026_bib55","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41420-023-01399-w","article-title":"The role of HDAC3 and its inhibitors in regulation of oxidative stress and chronic diseases","volume":"9","author":"He","year":"2023","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.ymthe.2025.04.026_bib56","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.molcel.2020.08.015","article-title":"Histone Deacetylase 3 Couples Mitochondria to Drive IL-1beta-Dependent Inflammation by Configuring Fatty Acid Oxidation","volume":"80","author":"Chi","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ymthe.2025.04.026_bib57","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1038\/s41467-020-17630-6","article-title":"Histone deacetylase 3 controls lung alveolar macrophage development and homeostasis","volume":"11","author":"Yao","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.04.026_bib58","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41421-023-00573-9","article-title":"HDAC1\/2\/3 are major histone desuccinylases critical for promoter desuccinylation","volume":"9","author":"Li","year":"2023","journal-title":"Cell Discov."},{"key":"10.1016\/j.ymthe.2025.04.026_bib59","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-32927-9","article-title":"Histone deacetylase (HDAC) 1 and 2 complexes regulate both histone acetylation and crotonylation in vivo","volume":"8","author":"Kelly","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2025.04.026_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2023.110875","article-title":"HDAC1 inhibits beige adipocyte-mediated thermogenesis through histone crotonylation of Pgc1a\/Ucp1","volume":"111","author":"Tian","year":"2023","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ymthe.2025.04.026_bib61","doi-asserted-by":"crossref","first-page":"207","DOI":"10.21037\/atm-22-4371","article-title":"Regulation of endothelial-to-mesenchymal transition by histone deacetylase 3 posttranslational modifications in neointimal hyperplasia","volume":"11","author":"Chen","year":"2023","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.ymthe.2025.04.026_bib62","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/cr.2017.68","article-title":"Class I histone deacetylases are major histone decrotonylases: evidence for critical and broad function of histone crotonylation in transcription","volume":"27","author":"Wei","year":"2017","journal-title":"Cell Res."},{"key":"10.1016\/j.ymthe.2025.04.026_bib63","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.chembiol.2018.04.007","article-title":"Histone Deacetylase 11 Is an epsilon-N-Myristoyllysine Hydrolase","volume":"25","author":"Moreno-Yruela","year":"2018","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib64","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/cr.2017.149","article-title":"Landscape of the regulatory elements for lysine 2-hydroxyisobutyrylation pathway","volume":"28","author":"Huang","year":"2018","journal-title":"Cell Res."},{"key":"10.1016\/j.ymthe.2025.04.026_bib65","doi-asserted-by":"crossref","first-page":"7295","DOI":"10.1096\/fj.201903254R","article-title":"Identification of histone deacetylase 8 as a novel therapeutic target for renal fibrosis","volume":"34","author":"Zhang","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.ymthe.2025.04.026_bib66","doi-asserted-by":"crossref","first-page":"F1003","DOI":"10.1152\/ajprenal.00261.2020","article-title":"Histone deacetylase 6 inhibition mitigates renal fibrosis by suppressing TGF-beta and EGFR signaling pathways in obstructive nephropathy","volume":"319","author":"Chen","year":"2020","journal-title":"Am. J. Physiol-renal"},{"key":"10.1016\/j.ymthe.2025.04.026_bib67","article-title":"HDAC6 regulates epidermal growth factor receptor (EGFR) endocytic trafficking and degradation in renal epithelial cells","volume":"7","author":"Liu","year":"2012","journal-title":"PLOS One"},{"key":"10.1016\/j.ymthe.2025.04.026_bib68","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20010102","article-title":"The Crosstalk between Acetylation and Phosphorylation: Emerging New Roles for HDAC Inhibitors in the Heart","volume":"20","author":"Habibian","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2025.04.026_bib69","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/BF00849241","article-title":"Early organogenesis of the kidney","volume":"1","author":"Saxen","year":"1987","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib70","doi-asserted-by":"crossref","first-page":"e338","DOI":"10.1002\/wdev.338","article-title":"Cellular and molecular determinants of normal and abnormal kidney development","volume":"8","author":"Tham","year":"2019","journal-title":"Wiley Interdiscip Rev. Dev. Biol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib71","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/nrneph.2016.157","article-title":"The contribution of branching morphogenesis to kidney development and disease","volume":"12","author":"Short","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib72","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ar.23930","article-title":"The Embryonic Ascent of the Kidney Revisited","volume":"302","author":"Fukuoka","year":"2019","journal-title":"Anat. Rec."},{"key":"10.1016\/j.ymthe.2025.04.026_bib73","article-title":"Current Epigenetic Insights in Kidney Development","volume":"12","author":"Chan","year":"2021","journal-title":"Genes-Basel"},{"key":"10.1016\/j.ymthe.2025.04.026_bib74","doi-asserted-by":"crossref","first-page":"32775","DOI":"10.1074\/jbc.M111.248278","article-title":"Histone deacetylase (HDAC) activity is critical for embryonic kidney gene expression, growth, and differentiation","volume":"286","author":"Chen","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2025.04.026_bib75","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/sctm.19-0289","article-title":"Epigenetic regulation of kidney progenitor cells","volume":"9","author":"Huang","year":"2020","journal-title":"Stem Cell Transl. Med."},{"key":"10.1016\/j.ymthe.2025.04.026_bib76","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3892\/ijmm.2017.3051","article-title":"Regulation of retinoic acid synthetic enzymes by WT1 and HDAC inhibitors in 293 cells","volume":"40","author":"Li","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ymthe.2025.04.026_bib77","first-page":"565","article-title":"Epigenetics of Renal Development and Disease","volume":"89","author":"Hilliard","year":"2016","journal-title":"Yale J. Biol. Med."},{"key":"10.1016\/j.ymthe.2025.04.026_bib78","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1093\/emboj\/21.11.2672","article-title":"Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression","volume":"21","author":"Lagger","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.ymthe.2025.04.026_bib79","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1242\/dev.113506","article-title":"Histone deacetylase 1 and 2 regulate Wnt and p53 pathways in the ureteric bud epithelium","volume":"142","author":"Chen","year":"2015","journal-title":"Development"},{"key":"10.1016\/j.ymthe.2025.04.026_bib80","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00467-012-2223-8","article-title":"Histone deacetylases in kidney development: implications for disease and therapy","volume":"28","author":"Chen","year":"2013","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib81","doi-asserted-by":"crossref","DOI":"10.1242\/dev.153619","article-title":"Histone deacetylases 1 and 2 regulate the transcriptional programs of nephron progenitors and renal vesicles","volume":"145","author":"Liu","year":"2018","journal-title":"Development"},{"key":"10.1016\/j.ymthe.2025.04.026_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115341","article-title":"Histone deacetylases 1 and 2 target gene regulatory networks of nephron progenitors to control nephrogenesis","volume":"206","author":"Liu","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib83","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ydbio.2012.11.018","article-title":"Mi-2\/NuRD is required in renal progenitor cells during embryonic kidney development","volume":"375","author":"Denner","year":"2013","journal-title":"Dev. Biol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib84","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1242\/dev.095851","article-title":"Sall1 balances self-renewal and differentiation of renal progenitor cells","volume":"141","author":"Basta","year":"2014","journal-title":"Development"},{"key":"10.1016\/j.ymthe.2025.04.026_bib85","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.semcdb.2018.08.014","article-title":"Epigenetic regulation of renal development","volume":"91","author":"El-Dahr","year":"2019","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib86","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00109-021-02141-8","article-title":"Histone deacetylase 3 (HDAC3) as an important epigenetic regulator of kidney diseases","volume":"100","author":"Zhang","year":"2022","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.ymthe.2025.04.026_bib87","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.gene.2009.03.014","article-title":"The homeodomain protein Cux1 interacts with Grg4 to repress p27 kip1 expression during kidney development","volume":"439","author":"Sharma","year":"2009","journal-title":"Gene"},{"key":"10.1016\/j.ymthe.2025.04.026_bib88","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.67828","article-title":"Targeting an anchored phosphatase-deacetylase unit restores renal ciliary homeostasis","volume":"10","author":"Gopalan","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.ymthe.2025.04.026_bib89","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.676214","article-title":"Loss of Deacetylation Enzymes Hdac6 and Sirt2 Promotes Acetylation of Cytoplasmic Tubulin, but Suppresses Axonemal Acetylation in Zebrafish Cilia","volume":"9","author":"Lysyganicz","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib90","doi-asserted-by":"crossref","first-page":"27527","DOI":"10.18632\/oncotarget.8374","article-title":"Functional interplay between cylindromatosis and histone deacetylase 6 in ciliary homeostasis revealed by phenotypic analysis of double knockout mice","volume":"7","author":"Ran","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ymthe.2025.04.026_bib91","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease","volume":"105","year":"2024","journal-title":"Kidney Int."},{"key":"10.1016\/j.ymthe.2025.04.026_bib93","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.569322","article-title":"New Insights Into the Role and Mechanism of Partial Epithelial-Mesenchymal Transition in Kidney Fibrosis","volume":"11","author":"Sheng","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib94","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1369\/0022155419849388","article-title":"Extracellular Matrix in Kidney Fibrosis: More Than Just a Scaffold","volume":"67","author":"Bulow","year":"2019","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.ymthe.2025.04.026_bib95","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1042\/CS20201016","article-title":"Interplay between extracellular matrix components and cellular and molecular mechanisms in kidney fibrosis","volume":"135","author":"Rayego-Mateos","year":"2021","journal-title":"Clin. Sci."},{"key":"10.1016\/j.ymthe.2025.04.026_bib96","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1159\/000505295","article-title":"Application of Histone Deacetylase Inhibitors in Renal Interstitial Fibrosis","volume":"6","author":"Nie","year":"2020","journal-title":"Kidney Dis."},{"key":"10.1016\/j.ymthe.2025.04.026_bib97","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3389\/fphys.2015.00121","article-title":"Treatment of chronic kidney diseases with histone deacetylase inhibitors","volume":"6","author":"Liu","year":"2015","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib98","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2024.13267","article-title":"TGF-beta\/Smad signaling in chronic kidney disease: Exploring post-translational regulatory perspectives","volume":"30","author":"Li","year":"2024","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ymthe.2025.04.026_bib99","doi-asserted-by":"crossref","first-page":"F596","DOI":"10.1152\/ajprenal.00365.2015","article-title":"TGF-beta signaling in the kidney: profibrotic and protective effects","volume":"310","author":"Sureshbabu","year":"2016","journal-title":"Am. J. Physiol-renal"},{"key":"10.1016\/j.ymthe.2025.04.026_bib100","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrneph.2016.48","article-title":"TGF-beta: the master regulator of fibrosis","volume":"12","author":"Meng","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib101","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/s41418-020-00631-9","article-title":"Histone deacetylase 3 aberration inhibits Klotho transcription and promotes renal fibrosis","volume":"28","author":"Chen","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ymthe.2025.04.026_bib102","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00109-016-1479-z","article-title":"TIMAP repression by TGFbeta and HDAC3-associated Smad signaling regulates macrophage M2 phenotypic phagocytosis","volume":"95","author":"Yang","year":"2017","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.ymthe.2025.04.026_bib103","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.kint.2017.02.023","article-title":"Klotho restoration via acetylation of Peroxisome Proliferation-Activated Receptor gamma reduces the progression of chronic kidney disease","volume":"92","author":"Lin","year":"2017","journal-title":"Kidney Int."},{"key":"10.1016\/j.ymthe.2025.04.026_bib104","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.cbpa.2016.06.019","article-title":"Histone deacetylase 3 (HDAC 3) as emerging drug target in NF-kappaB-mediated inflammation","volume":"33","author":"Leus","year":"2016","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib105","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/s41392-022-01036-5","article-title":"Signaling pathways of chronic kidney diseases, implications for therapeutics","volume":"7","author":"Yuan","year":"2022","journal-title":"Signal. Transduct. Tar."},{"key":"10.1016\/j.ymthe.2025.04.026_bib106","doi-asserted-by":"crossref","DOI":"10.3390\/cells9061348","article-title":"NF-kappaB and tPA Signaling in Kidney and Other Diseases","volume":"9","author":"White","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ymthe.2025.04.026_bib107","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.kint.2024.04.016","article-title":"The glycolytic enzyme PFKFB3 drives kidney fibrosis through promoting histone lactylation-mediated NF-kappaB family activation","volume":"106","author":"Wang","year":"2024","journal-title":"Kidney Int."},{"key":"10.1016\/j.ymthe.2025.04.026_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102939","article-title":"HDAC3 aberration-incurred GPX4 suppression drives renal ferroptosis and AKI-CKD progression","volume":"68","author":"Zhang","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib109","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1080\/15384101.2021.1989899","article-title":"Depleted HDAC3 attenuates hyperuricemia-induced renal interstitial fibrosis via miR-19b-3p\/SF3B3 axis","volume":"21","author":"Hu","year":"2022","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ymthe.2025.04.026_bib110","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231710014","article-title":"A Therapeutic Perspective of HDAC8 in Different Diseases: An Overview of Selective Inhibitors","volume":"23","author":"Fontana","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2025.04.026_bib111","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41392-023-01379-7","article-title":"Kidney fibrosis: from mechanisms to therapeutic medicines","volume":"8","author":"Huang","year":"2023","journal-title":"Signal. Transduct. Tar."},{"key":"10.1016\/j.ymthe.2025.04.026_bib112","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/aps.2015.79","article-title":"Histone deacetylase inhibitors attenuate P-aIgA1-induced cell proliferation and extracellular matrix synthesis in human renal mesangial cells in vitro","volume":"37","author":"Dai","year":"2016","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ymthe.2025.04.026_bib113","doi-asserted-by":"crossref","first-page":"F781","DOI":"10.1152\/ajprenal.00166.2017","article-title":"Inhibition of HDAC enhances STAT acetylation, blocks NF-kappaB, and suppresses the renal inflammation and fibrosis in Npr1 haplotype male mice","volume":"313","author":"Kumar","year":"2017","journal-title":"Am. J. Physiol-renal"},{"key":"10.1016\/j.ymthe.2025.04.026_bib114","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1681\/ASN.2019070739","article-title":"Loss of Histone H3 K79 Methyltransferase Dot1l Facilitates Kidney Fibrosis by Upregulating Endothelin 1 through Histone Deacetylase 2","volume":"31","author":"Zhang","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib115","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.929334","article-title":"Pharmacological and Genetic Inhibition of HDAC4 Alleviates Renal Injury and Fibrosis in Mice","volume":"13","author":"Shen","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib116","doi-asserted-by":"crossref","first-page":"8249","DOI":"10.1096\/fj.201801067RR","article-title":"Selective inhibition of class IIa histone deacetylases alleviates renal fibrosis","volume":"33","author":"Xiong","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.ymthe.2025.04.026_bib117","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.23617","article-title":"SNHG16\/miR-205\/HDAC5 is involved in the progression of renal fibrosis","volume":"38","author":"Zhao","year":"2024","journal-title":"J. Biochem. Mol. Toxic"},{"key":"10.1016\/j.ymthe.2025.04.026_bib118","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202301595RRR","article-title":"GRK5 promoted renal fibrosis via HDAC5\/Smad3 signaling pathway","volume":"38","author":"Xiang","year":"2024","journal-title":"FASEB J."},{"key":"10.1016\/j.ymthe.2025.04.026_bib119","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.vph.2015.04.006","article-title":"Tubastatin A suppresses renal fibrosis via regulation of epigenetic histone modification and Smad3-dependent fibrotic genes","volume":"72","author":"Choi","year":"2015","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib120","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1080\/15548627.2016.1190071","article-title":"Atg5-mediated autophagy deficiency in proximal tubules promotes cell cycle G2\/M arrest and renal fibrosis","volume":"12","author":"Li","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.ymthe.2025.04.026_bib121","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nm.2144","article-title":"Epithelial cell cycle arrest in G2\/M mediates kidney fibrosis after injury","volume":"16","author":"Yang","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.04.026_bib122","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1038\/s41467-023-38771-4","article-title":"HDAC9-mediated epithelial cell cycle arrest in G2\/M contributes to kidney fibrosis in male mice","volume":"14","author":"Zhang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.04.026_bib123","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3389\/fcell.2020.00235","article-title":"Histone Deacetylase 11 Contributes to Renal Fibrosis by Repressing KLF15 Transcription","volume":"8","author":"Mao","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib124","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.kint.2017.03.037","article-title":"The loss of Kruppel-like factor 15 in Foxd1(+) stromal cells exacerbates kidney fibrosis","volume":"92","author":"Gu","year":"2017","journal-title":"Kidney Int."},{"key":"10.1016\/j.ymthe.2025.04.026_bib125","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/ki.2010.539","article-title":"Low-protein diet supplemented with ketoacids reduces the severity of renal disease in 5\/6 nephrectomized rats: a role for KLF15","volume":"79","author":"Gao","year":"2011","journal-title":"Kidney Int."},{"key":"10.1016\/j.ymthe.2025.04.026_bib126","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1159\/000355743","article-title":"Kruppel-like factor 15 modulates renal interstitial fibrosis by ERK\/MAPK and JNK\/MAPK pathways regulation","volume":"37","author":"Gao","year":"2013","journal-title":"Kidney Blood Press. R."},{"key":"10.1016\/j.ymthe.2025.04.026_bib127","first-page":"1","article-title":"KDIGO clinical practice guideline for acute kidney injury","author":"KDIGO","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/j.ymthe.2025.04.026_bib128","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/ki.2013.153","article-title":"Raising awareness of acute kidney injury: a global perspective of a silent killer","volume":"84","author":"Lewington","year":"2013","journal-title":"Kidney Int."},{"key":"10.1016\/j.ymthe.2025.04.026_bib129","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.1795","article-title":"Incidence and Prognosis of Acute Kidney Diseases and Disorders Using an Integrated Approach to Laboratory Measurements in a Universal Health Care System","volume":"2","author":"James","year":"2019","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.ymthe.2025.04.026_bib130","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1053\/j.ackd.2012.12.003","article-title":"Acute kidney injury: global health alert","volume":"20","author":"Li","year":"2013","journal-title":"Adv. Chron. Kidney D"},{"key":"10.1016\/j.ymthe.2025.04.026_bib131","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1056\/NEJMra1214243","article-title":"Acute kidney injury and chronic kidney disease as interconnected syndromes","volume":"371","author":"Chawla","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2025.04.026_bib132","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/978-981-15-4272-5_34","article-title":"Autophagy and Acute Kidney Injury","volume":"1207","author":"Cui","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib133","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1080\/15548627.2022.2084862","article-title":"Mitochondria ROS and mitophagy in acute kidney injury","volume":"19","author":"Su","year":"2023","journal-title":"Autophagy"},{"key":"10.1016\/j.ymthe.2025.04.026_bib134","doi-asserted-by":"crossref","DOI":"10.3390\/biom10010100","article-title":"Autophagy Function and Regulation in Kidney Disease","volume":"10","author":"Kaushal","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.ymthe.2025.04.026_bib135","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.163161","article-title":"Glutamine prevents acute kidney injury by modulating oxidative stress and apoptosis in tubular epithelial cells","volume":"7","author":"Thomas","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymthe.2025.04.026_bib136","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41419-024-06449-4","article-title":"DDRGK1-mediated ER-phagy attenuates acute kidney injury through ER-stress and apoptosis","volume":"15","author":"Jin","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ymthe.2025.04.026_bib137","doi-asserted-by":"crossref","DOI":"10.3390\/biom11081144","article-title":"Mitochondrial Redox Signaling and Oxidative Stress in Kidney Diseases","volume":"11","author":"Aranda-Rivera","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.ymthe.2025.04.026_bib138","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.7150\/thno.50905","article-title":"Mitochondrial ROS promote mitochondrial dysfunction and inflammation in ischemic acute kidney injury by disrupting TFAM-mediated mtDNA maintenance","volume":"11","author":"Zhao","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.ymthe.2025.04.026_bib139","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.freeradbiomed.2020.09.011","article-title":"Oxidative stress and inflammasome activation in human rhabdomyolysis-induced acute kidney injury","volume":"160","author":"Grivei","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ymthe.2025.04.026_bib140","doi-asserted-by":"crossref","first-page":"F244","DOI":"10.1152\/ajprenal.00126.2013","article-title":"Class I histone deacetylase activity is required for proliferation of renal epithelial cells","volume":"305","author":"Tang","year":"2013","journal-title":"AM. J. Physiol-renal"},{"key":"10.1016\/j.ymthe.2025.04.026_bib141","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1007\/s00018-012-0921-9","article-title":"Multiple roles of class I HDACs in proliferation, differentiation, and development","volume":"69","author":"Reichert","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ymthe.2025.04.026_bib142","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1038\/s44319-024-00210-w","article-title":"Reversible acetylation of HDAC8 regulates cell cycle","volume":"25","author":"Sang","year":"2024","journal-title":"EMBO Rep."},{"key":"10.1016\/j.ymthe.2025.04.026_bib143","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1097\/01.ASN.0000067652.51441.21","article-title":"Dedifferentiation and proliferation of surviving epithelial cells in acute renal failure","volume":"14","author":"Bonventre","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib144","doi-asserted-by":"crossref","first-page":"F303","DOI":"10.1152\/ajprenal.00102.2014","article-title":"Class I HDAC activity is required for renal protection and regeneration after acute kidney injury","volume":"307","author":"Tang","year":"2014","journal-title":"AM. J. Physiol-renal"},{"key":"10.1016\/j.ymthe.2025.04.026_bib145","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/ki.2015.326","article-title":"Histone deacetylase\u2013mediated silencing of AMWAP expression contributes to cisplatin nephrotoxicity","volume":"89","author":"Ranganathan","year":"2016","journal-title":"Kidney Int."},{"key":"10.1016\/j.ymthe.2025.04.026_bib146","article-title":"VPA improves ferroptosis in tubular epithelial cells after cisplatin-induced acute kidney injury","volume":"14","author":"Li","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib147","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.552","article-title":"Suppression of BMP-7 by histone deacetylase 2 promoted apoptosis of renal tubular epithelial cells in acute kidney injury","volume":"8","author":"Ma","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ymthe.2025.04.026_bib148","article-title":"A potential adjuvant chemotherapeutics, 18\u03b2-glycyrrhetinic acid, inhibits renal tubular epithelial cells apoptosis via enhancing BMP-7 epigenetically through targeting HDAC2","volume":"6","author":"Ma","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2025.04.026_bib149","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70114","article-title":"Inhibition of HDAC8 mitigates AKI by reducing DNA damage and promoting homologous recombination repair","volume":"28","author":"Wang","year":"2024","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.ymthe.2025.04.026_bib150","doi-asserted-by":"crossref","first-page":"F1443","DOI":"10.1152\/ajprenal.00143.2012","article-title":"alpha2-Adrenoceptor agonist dexmedetomidine protects septic acute kidney injury through increasing BMP-7 and inhibiting HDAC2 and HDAC5","volume":"303","author":"Hsing","year":"2012","journal-title":"AM. J. Physiol-renal"},{"key":"10.1016\/j.ymthe.2025.04.026_bib151","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00011-022-01653-4","article-title":"Human bone marrow mesenchymal stem cell-derived extracellular vesicles reduce inflammation and pyroptosis in acute kidney injury via miR-223-3p\/HDAC2\/SNRK","volume":"72","author":"Xie","year":"2023","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.ymthe.2025.04.026_bib152","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2024.110009","article-title":"Inhibition of HDAC6 with CAY10603 alleviates acute and chronic kidney injury by suppressing the ATF6 branch of UPR","volume":"756","author":"Kan","year":"2024","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ymthe.2025.04.026_bib153","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1042\/CS20171417","article-title":"Blockade of histone deacetylase 6 protects against cisplatin-induced acute kidney injury","volume":"132","author":"Tang","year":"2018","journal-title":"Clin. Sci."},{"key":"10.1016\/j.ymthe.2025.04.026_bib154","article-title":"2-methylquinazoline derivative F7 as a potent and selective HDAC6 inhibitor protected against rhabdomyolysis-induced acute kidney injury","volume":"14","author":"Liu","year":"2019","journal-title":"PLOS One"},{"key":"10.1016\/j.ymthe.2025.04.026_bib155","doi-asserted-by":"crossref","first-page":"F502","DOI":"10.1152\/ajprenal.00546.2016","article-title":"Inhibition of HDAC6 protects against rhabdomyolysis-induced acute kidney injury","volume":"312","author":"Shi","year":"2017","journal-title":"AM. J. Physiol-renal"},{"key":"10.1016\/j.ymthe.2025.04.026_bib156","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3389\/fphar.2018.00274","article-title":"Selective Histone Deacetylase 6 Inhibitor 23BB Alleviated Rhabdomyolysis-Induced Acute Kidney Injury by Regulating Endoplasmic Reticulum Stress and Apoptosis","volume":"9","author":"Feng","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib157","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1080\/15548627.2016.1159376","article-title":"Time-dependent dysregulation of autophagy: Implications in aging and mitochondrial homeostasis in the kidney proximal tubule","volume":"12","author":"Yamamoto","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.ymthe.2025.04.026_bib158","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/417455a","article-title":"HDAC6 is a microtubule-associated deacetylase","volume":"417","author":"Hubbert","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.04.026_bib159","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nchembio.2140","article-title":"Structural insights into HDAC6 tubulin deacetylation and its selective inhibition","volume":"12","author":"Miyake","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib160","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/kjm2.12431","article-title":"Downregulation of miR-29b-3p aggravates podocyte injury by targeting HDAC4 in LPS-induced acute kidney injury","volume":"37","author":"Ha","year":"2021","journal-title":"Kaohsiung J. Med. Sci."},{"key":"10.1016\/j.ymthe.2025.04.026_bib161","article-title":"Class IIa histone deacetylase inhibition ameliorates acute kidney injury by suppressing renal tubular cell apoptosis and enhancing autophagy and proliferation","volume":"13","author":"Li","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib162","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23063317","article-title":"Autosomal Dominant Polycystic Kidney Disease: From Pathophysiology of Cystogenesis to Advances in the Treatment","volume":"23","author":"Reiterova","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2025.04.026_bib163","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1093\/ndt\/gfw240","article-title":"Prevalence of autosomal dominant polycystic kidney disease in the European Union","volume":"32","author":"Willey","year":"2017","journal-title":"Nephrol. Dial. Transpl."},{"key":"10.1016\/j.ymthe.2025.04.026_bib164","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1681\/ASN.2018050493","article-title":"Prevalence Estimates of Polycystic Kidney and Liver Disease by Population Sequencing","volume":"29","author":"Lanktree","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib165","doi-asserted-by":"crossref","first-page":"790","DOI":"10.2215\/CJN.02320220","article-title":"Insights into Autosomal Dominant Polycystic Kidney Disease from Genetic Studies","volume":"16","author":"Lanktree","year":"2021","journal-title":"Clin. J. Am. Soc. Nephro."},{"key":"10.1016\/j.ymthe.2025.04.026_bib166","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1056\/NEJMoa1710030","article-title":"Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease","volume":"377","author":"Torres","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2025.04.026_bib167","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/ndt\/gfs551","article-title":"Epidemiology of autosomal-dominant polycystic kidney disease: an in-depth clinical study for south-western Germany","volume":"28","author":"Neumann","year":"2013","journal-title":"Nephrol. Dial. Transpl."},{"key":"10.1016\/j.ymthe.2025.04.026_bib168","doi-asserted-by":"crossref","first-page":"iv15","DOI":"10.1093\/ndt\/gfu017","article-title":"Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival--an analysis of data from the ERA-EDTA Registry","volume":"29","author":"Spithoven","year":"2014","journal-title":"Nephrol. Dial. Transpl."},{"key":"10.1016\/j.ymthe.2025.04.026_bib169","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000499368","article-title":"Histone Deacetylase Inhibitors Reduce Cysts by Activating Autophagy in Polycystic Kidney Disease","volume":"5","author":"Sun","year":"2019","journal-title":"Kidney Dis."},{"key":"10.1016\/j.ymthe.2025.04.026_bib170","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ki.2011.296","article-title":"Inhibition of histone deacetylases targets the transcription regulator Id2 to attenuate cystic epithelial cell proliferation","volume":"81","author":"Fan","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/j.ymthe.2025.04.026_bib171","doi-asserted-by":"crossref","first-page":"17897","DOI":"10.1074\/jbc.M117.803775","article-title":"Histone deacetylase 6 inhibition reduces cysts by decreasing cAMP and Ca(2+) in knock-out mouse models of polycystic kidney disease","volume":"292","author":"Yanda","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2025.04.026_bib172","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.bbadis.2010.10.008","article-title":"Epigenetics and autosomal dominant polycystic kidney disease","volume":"1812","author":"Li","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymthe.2025.04.026_bib173","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.kint.2016.01.026","article-title":"Inhibition of histone deacetylase 6 activity reduces cyst growth in polycystic kidney disease","volume":"90","author":"Cebotaru","year":"2016","journal-title":"Kidney Int."},{"key":"10.1016\/j.ymthe.2025.04.026_bib174","doi-asserted-by":"crossref","first-page":"6383","DOI":"10.1128\/MCB.00254-07","article-title":"TAZ promotes PC2 degradation through a SCFbeta-Trcp E3 ligase complex","volume":"27","author":"Tian","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib175","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41581-019-0143-6","article-title":"Structure and function of polycystins: insights into polycystic kidney disease","volume":"15","author":"Douguet","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib176","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41581-018-0108-1","article-title":"Progress in the understanding of polycystic kidney disease","volume":"15","author":"Torres","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib177","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/emboj.2009.405","article-title":"HDAC6 controls autophagosome maturation essential for ubiquitin-selective quality-control autophagy","volume":"29","author":"Lee","year":"2010","journal-title":"EMBO J."},{"key":"10.1016\/j.ymthe.2025.04.026_bib178","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.molcel.2009.04.026","article-title":"A role for ubiquitin in selective autophagy","volume":"34","author":"Kirkin","year":"2009","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ymthe.2025.04.026_bib179","doi-asserted-by":"crossref","first-page":"6404","DOI":"10.1074\/jbc.M113.501205","article-title":"Polycystin-1 negatively regulates Polycystin-2 expression via the aggresome\/autophagosome pathway","volume":"289","author":"Cebotaru","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2025.04.026_bib180","doi-asserted-by":"crossref","first-page":"C487","DOI":"10.1152\/ajpcell.1995.269.2.C487","article-title":"Abnormal polarization of EGF receptors and autocrine stimulation of cyst epithelial growth in human ADPKD","volume":"269","author":"Du","year":"1995","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib181","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.kint.2016.02.044","article-title":"Histone deacetylases 6 increases the cyclic adenosine monophosphate level and promotes renal cyst growth","volume":"90","author":"Wu","year":"2016","journal-title":"Kidney Int."},{"key":"10.1016\/j.ymthe.2025.04.026_bib182","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202100325RR","article-title":"Polycystin-1 dependent regulation of polycystin-2 via GRP94, a member of HSP90 family that resides in the endoplasmic reticulum","volume":"35","author":"Yao","year":"2021","journal-title":"FASEB J."},{"key":"10.1016\/j.ymthe.2025.04.026_bib183","doi-asserted-by":"crossref","first-page":"5724","DOI":"10.7150\/ijbs.76140","article-title":"HDAC5-mediated Smad7 silencing through MEF2A is critical for fibroblast activation and hypertrophic scar formation","volume":"18","author":"Gao","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ymthe.2025.04.026_bib184","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.7150\/thno.69444","article-title":"HDAC5 modulates PD-L1 expression and cancer immunity via p65 deacetylation in pancreatic cancer","volume":"12","author":"Zhou","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.ymthe.2025.04.026_bib185","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41416-023-02341-8","article-title":"HDAC5 modulates SATB1 transcriptional activity to promote lung adenocarcinoma","volume":"129","author":"Sharma","year":"2023","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ymthe.2025.04.026_bib186","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1242\/dev.049437","article-title":"Polycystin-dependent fluid flow sensing targets histone deacetylase 5 to prevent the development of renal cysts","volume":"137","author":"Xia","year":"2010","journal-title":"Development"},{"key":"10.1016\/j.ymthe.2025.04.026_bib187","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0216220","article-title":"Dopamine receptor antagonists as potential therapeutic agents for ADPKD","volume":"14","author":"Paul","year":"2019","journal-title":"PLOS One"},{"key":"10.1016\/j.ymthe.2025.04.026_bib188","article-title":"Cux1 regulation of the cyclin kinase inhibitor p27(kip1) in polycystic kidney disease is attenuated by HDAC inhibitors","volume":"2","author":"Livingston","year":"2019","journal-title":"GENE"},{"key":"10.1016\/j.ymthe.2025.04.026_bib189","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/1497449","article-title":"Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment","volume":"2021","author":"Samsu","year":"2021","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.ymthe.2025.04.026_bib190","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/8637138","article-title":"Classification and Differential Diagnosis of Diabetic Nephropathy","volume":"2017","author":"Qi","year":"2017","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.ymthe.2025.04.026_bib191","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2337\/dc20-1913","article-title":"Worldwide Epidemiology of Diabetes-Related End-Stage Renal Disease, 2000-2015","volume":"44","author":"Cheng","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ymthe.2025.04.026_bib192","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/joim.13424","article-title":"Can we cure diabetic kidney disease? Present and future perspectives from a nephrologist's point of view","volume":"291","author":"Guedes","year":"2022","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ymthe.2025.04.026_bib193","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1185317","article-title":"Oxidative stress and inflammation in diabetic nephropathy: role of polyphenols","volume":"14","author":"Jin","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib194","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.2174\/1389450123666220820110801","article-title":"Diabetic Nephropathy: Pathogenesis to Cure","volume":"23","author":"Kushwaha","year":"2022","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.ymthe.2025.04.026_bib195","doi-asserted-by":"crossref","first-page":"181","DOI":"10.4093\/dmj.2021.0329","article-title":"Pathophysiologic Mechanisms and Potential Biomarkers in Diabetic Kidney Disease","volume":"46","author":"Jung","year":"2022","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.ymthe.2025.04.026_bib196","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3724\/abbs.2021016","article-title":"Epigenetics in the pathogenesis of diabetic nephropathy","volume":"54","author":"Li","year":"2022","journal-title":"Acta Bioch. Bioph. Sin."},{"key":"10.1016\/j.ymthe.2025.04.026_bib197","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.120194","article-title":"Epigenetic restoration of endogenous Klotho expression alleviates acute kidney injury-diabetes comorbidity","volume":"288","author":"Kale","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.ymthe.2025.04.026_bib198","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s40001-022-00679-y","article-title":"Knockdown of circ_0003928 ameliorates high glucose-induced dysfunction of human tubular epithelial cells through the miR-506-3p\/HDAC4 pathway in diabetic nephropathy","volume":"27","author":"Liu","year":"2022","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.ymthe.2025.04.026_bib199","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1055\/a-1480-7519","article-title":"miRNA-483-5p Targets HDCA4 to Regulate Renal Tubular Damage in Diabetic Nephropathy","volume":"53","author":"Liu","year":"2021","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.ymthe.2025.04.026_bib200","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.bbrc.2020.09.121","article-title":"Histone deacetylase 4 mediates high glucose-induced podocyte apoptosis via upregulation of calcineurin","volume":"533","author":"Shi","year":"2020","journal-title":"Biochem. Bioph Res. Co."},{"key":"10.1016\/j.ymthe.2025.04.026_bib201","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/ki.2014.111","article-title":"Histone deacetylase 4 selectively contributes to podocyte injury in diabetic nephropathy","volume":"86","author":"Wang","year":"2014","journal-title":"Kidney Int."},{"key":"10.1016\/j.ymthe.2025.04.026_bib202","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1021\/acs.molpharmaceut.0c00094","article-title":"Cyclo-RGD Truncated Polymeric Nanoconstruct with Dendrimeric Templates for Targeted HDAC4 Gene Silencing in a Diabetic Nephropathy Mouse Model","volume":"18","author":"Raval","year":"2021","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ymthe.2025.04.026_bib203","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1681\/ASN.2013050527","article-title":"MicroRNA-29a promotion of nephrin acetylation ameliorates hyperglycemia-induced podocyte dysfunction","volume":"25","author":"Lin","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib204","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/ki.2014.142","article-title":"HDAC4 blocks autophagy to trigger podocyte injury: non-epigenetic action in diabetic nephropathy","volume":"86","author":"Wei","year":"2014","journal-title":"Kidney Int."},{"key":"10.1016\/j.ymthe.2025.04.026_bib205","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/nep.13451","article-title":"Glomerular mesangial cell and podocyte injuries in diabetic nephropathy","volume":"23","author":"Tung","year":"2018","journal-title":"Nephrology"},{"key":"10.1016\/j.ymthe.2025.04.026_bib206","doi-asserted-by":"crossref","first-page":"11558","DOI":"10.1111\/jcmm.15772","article-title":"HDAC6-mediated alpha-tubulin deacetylation suppresses autophagy and enhances motility of podocytes in diabetic nephropathy","volume":"24","author":"Liang","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.ymthe.2025.04.026_bib207","first-page":"1097","article-title":"Inhibition of Histone Deacetylase 6 Ameliorates Podocyte Injury in Diabetic Kidney Disease in Mice","volume":"54","author":"Hou","year":"2023","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.ymthe.2025.04.026_bib208","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.938391","article-title":"Inhibition of HDAC6 With CAY10603 Ameliorates Diabetic Kidney Disease by Suppressing NLRP3 Inflammasome","volume":"13","author":"Hou","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib209","first-page":"464","article-title":"Intervention and therapeutic effect of siRNA-HDAC5 on abnormal histone modification in non-obese diabetic mice","volume":"40","author":"Ouyang","year":"2015","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.ymthe.2025.04.026_bib210","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41419-020-03312-0","article-title":"METTL14-regulated PI3K\/Akt signaling pathway via PTEN affects HDAC5-mediated epithelial-mesenchymal transition of renal tubular cells in diabetic kidney disease","volume":"12","author":"Xu","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ymthe.2025.04.026_bib211","first-page":"1047","article-title":"LINC00162 participates in the pathogenesis of diabetic nephropathy via modulating the miR-383\/HDAC9 signalling pathway","volume":"48","author":"Fan","year":"2020","journal-title":"Artif. Cell Nanomed. B."},{"key":"10.1016\/j.ymthe.2025.04.026_bib212","doi-asserted-by":"crossref","first-page":"F729","DOI":"10.1152\/ajprenal.00086.2009","article-title":"Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury","volume":"297","author":"Noh","year":"2009","journal-title":"AM. J. Physiol-renal"},{"key":"10.1016\/j.ymthe.2025.04.026_bib213","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3803\/EnM.2021.1336","article-title":"Short-Chain Fatty Acids Attenuate Renal Fibrosis and Enhance Autophagy of Renal Tubular Cells in Diabetic Mice Through the HDAC2\/ULK1 Axis","volume":"37","author":"Ma","year":"2022","journal-title":"Endocrinol. Metab."},{"key":"10.1016\/j.ymthe.2025.04.026_bib214","first-page":"210","article-title":"Suppression of HDAC2 by sodium butyrate alleviates apoptosis of kidney cells in db\/db mice and HG-induced NRK-52E cells","volume":"45","author":"Du","year":"2020","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ymthe.2025.04.026_bib215","doi-asserted-by":"crossref","first-page":"909","DOI":"10.4093\/dmj.2020.0168","article-title":"Sulforaphane Ameliorates Diabetes-Induced Renal Fibrosis through Epigenetic Up-Regulation of BMP-7","volume":"45","author":"Kong","year":"2021","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.ymthe.2025.04.026_bib216","doi-asserted-by":"crossref","first-page":"9440","DOI":"10.1074\/jbc.RA118.007023","article-title":"Deacetylation of S6 kinase promotes high glucose-induced glomerular mesangial cell hypertrophy and matrix protein accumulation","volume":"294","author":"Das","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2025.04.026_bib217","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154700","article-title":"Rutin alleviates EndMT by restoring autophagy through inhibiting HDAC1 via PI3K\/AKT\/mTOR pathway in diabetic kidney disease","volume":"112","author":"Dong","year":"2023","journal-title":"Phytomedicine."},{"key":"10.1016\/j.ymthe.2025.04.026_bib218","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.2147\/DMSO.S286191","article-title":"Mesenchymal Stem Cell-Derived Exosomes Carry MicroRNA-125a to Protect Against Diabetic Nephropathy by Targeting Histone Deacetylase 1 and Downregulating Endothelin-1","volume":"14","author":"Hao","year":"2021","journal-title":"Diabet. Metab. Synd. Ob"},{"key":"10.1016\/j.ymthe.2025.04.026_bib219","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.taap.2016.06.010","article-title":"Epigenetic modification of miR-10a regulates renal damage by targeting CREB1 in type 2 diabetes mellitus","volume":"306","author":"Shan","year":"2016","journal-title":"Toxicol. Appl. Pharm."},{"key":"10.1016\/j.ymthe.2025.04.026_bib220","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.9","article-title":"Renal cell carcinoma","volume":"3","author":"Hsieh","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ymthe.2025.04.026_bib221","article-title":"Renal cell carcinoma: an overview of the epidemiology, diagnosis, and treatment","volume":"39","author":"Bahadoram","year":"2022","journal-title":"G. Ital. Nefrol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib222","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA. Cancer J. Clin."},{"key":"10.1016\/j.ymthe.2025.04.026_bib223","doi-asserted-by":"crossref","first-page":"E154","DOI":"10.5489\/cuaj.4464","article-title":"Epidemiology of renal cancer in developing countries: Review of the literature","volume":"12","author":"Medina-Rico","year":"2018","journal-title":"Cuaj-Can Urol. Assoc."},{"key":"10.1016\/j.ymthe.2025.04.026_bib224","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1007\/s00204-018-2229-5","article-title":"The histone deacetylases HDAC1 and HDAC2 are required for the growth and survival of renal carcinoma cells","volume":"92","author":"Kiweler","year":"2018","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib225","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.canlet.2018.06.009","article-title":"HDAC1-induced epigenetic silencing of ASPP2 promotes cell motility, tumour growth and drug resistance in renal cell carcinoma","volume":"432","author":"Li","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ymthe.2025.04.026_bib226","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/ncb3050","article-title":"ASPP2 controls epithelial plasticity and inhibits metastasis through beta-catenin-dependent regulation of ZEB1","volume":"16","author":"Wang","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib227","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/cac2.12142","article-title":"Junction plakoglobin regulates and destabilizes HIF2alpha to inhibit tumorigenesis of renal cell carcinoma","volume":"41","author":"Chen","year":"2021","journal-title":"Cancer Commun."},{"key":"10.1016\/j.ymthe.2025.04.026_bib228","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102692","article-title":"CBX4 transcriptionally suppresses KLF6 via interaction with HDAC1 to exert oncogenic activities in clear cell renal cell carcinoma","volume":"53","author":"Jiang","year":"2020","journal-title":"Ebiomedicine"},{"key":"10.1016\/j.ymthe.2025.04.026_bib229","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jare.2024.04.032","article-title":"MIER2\/PGC1A elicits sunitinib resistance via lipid metabolism in renal cell carcinoma","volume":"70","author":"Wei","year":"2025","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.ymthe.2025.04.026_bib230","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1186\/s12885-016-2604-7","article-title":"HDAC 1 and 6 modulate cell invasion and migration in clear cell renal cell carcinoma","volume":"16","author":"Ramakrishnan","year":"2016","journal-title":"BMC Can."},{"key":"10.1016\/j.ymthe.2025.04.026_bib231","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1038\/s41467-020-17873-3","article-title":"HIF-1alpha and HIF-2alpha differently regulate tumour development and inflammation of clear cell renal cell carcinoma in mice","volume":"11","author":"Hoefflin","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.04.026_bib232","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41392-023-01362-2","article-title":"Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinoma","volume":"8","author":"Hu","year":"2023","journal-title":"Signal. Transduct. Tar."},{"key":"10.1016\/j.ymthe.2025.04.026_bib233","article-title":"Loss of Von Hippel-Lindau (VHL) Tumor Suppressor Gene Function: VHL-HIF Pathway and Advances in Treatments for Metastatic Renal Cell Carcinoma (RCC)","volume":"22","author":"Kim","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2025.04.026_bib234","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/S10059-012-2268-3","article-title":"pVHL-mediated transcriptional repression of c-Myc by recruitment of histone deacetylases","volume":"33","author":"Hwang","year":"2012","journal-title":"Mol. Cells"},{"key":"10.1016\/j.ymthe.2025.04.026_bib235","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13148-022-01336-1","article-title":"PDCD5 inhibits progression of renal cell carcinoma by promoting T cell immunity: with the involvement of the HDAC3\/microRNA-195-5p\/SGK1","volume":"14","author":"Liu","year":"2022","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.ymthe.2025.04.026_bib236","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13062-024-00480-3","article-title":"Acetylation- and ubiquitination-regulated SFMBT2 acts as a tumor suppressor in clear cell renal cell carcinoma","volume":"19","author":"Xie","year":"2024","journal-title":"Biol. Direct"},{"key":"10.1016\/j.ymthe.2025.04.026_bib237","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3233\/CBM-160298","article-title":"HDAC6 serves as a biomarker for the prognosis of patients with renal cell carcinoma","volume":"19","author":"Zhang","year":"2017","journal-title":"Cancer Biomark."},{"key":"10.1016\/j.ymthe.2025.04.026_bib238","first-page":"3734","article-title":"Histone deacetylase 10 suppresses proliferation and invasion by inhibiting the phosphorylation of beta-catenin and serves as an independent prognostic factor for human clear cell renal cell carcinoma","volume":"8","author":"Fan","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.ymthe.2025.04.026_bib239","doi-asserted-by":"crossref","first-page":"6503","DOI":"10.1002\/cam4.4156","article-title":"Comprehensive analysis of a new prognosis signature based on histone deacetylases in clear cell renal cell carcinoma","volume":"10","author":"Cheng","year":"2021","journal-title":"Cancer Med."},{"key":"10.1016\/j.ymthe.2025.04.026_bib240","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202401142","article-title":"HDAC8 Enhances the Function of HIF-2alpha by Deacetylating ETS1 to Decrease the Sensitivity of TKIs in ccRCC","volume":"11","author":"Qian","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ymthe.2025.04.026_bib241","doi-asserted-by":"crossref","first-page":"740.e1","DOI":"10.1016\/j.urolonc.2020.03.006","article-title":"Decreased expression and hypomethylation of HDAC9 lead to poor prognosis and inhibit immune cell infiltration in clear cell renal cell carcinoma","volume":"38","author":"Fu","year":"2020","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib242","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1681\/ASN.2022050598","article-title":"Cell Cycle and Senescence Regulation by Podocyte Histone Deacetylase 1 and 2","volume":"34","author":"Medina Rangel","year":"2023","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib243","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1172\/JCI124030","article-title":"Podocyte histone deacetylase activity regulates murine and human glomerular diseases","volume":"129","author":"Inoue","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2025.04.026_bib244","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00109-015-1340-9","article-title":"TGF-beta induces miR-30d down-regulation and podocyte injury through Smad2\/3 and HDAC3-associated transcriptional repression","volume":"94","author":"Liu","year":"2016","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.ymthe.2025.04.026_bib245","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.107009","article-title":"Histone deacetylase 9 exacerbates podocyte injury in hyperhomocysteinemia through epigenetic repression of Klotho","volume":"198","author":"Liu","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ymthe.2025.04.026_bib246","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111057","article-title":"Histone deacetylase 6 suppression of renal tubular epithelial cell promotes interstitial mineral deposition via alpha-tubulin acetylation","volume":"116","author":"Li","year":"2024","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ymthe.2025.04.026_bib247","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109264","article-title":"HDAC5 RNA interference ameliorates acute renal injury by upregulating KLF2 and inhibiting NALP3 expression in a mouse model of oxalate nephropathy","volume":"112","author":"Sharma","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib248","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3109\/15376516.2014.920448","article-title":"Expression of histone deacetylase-1 and p300 in aristolochic acid nephropathy models","volume":"24","author":"Tian","year":"2014","journal-title":"Toxicol. Mech. Method"},{"key":"10.1016\/j.ymthe.2025.04.026_bib249","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.lfs.2019.03.008","article-title":"beta-Hydroxybutyrate, a ketone body, reduces the cytotoxic effect of cisplatin via activation of HDAC5 in human renal cortical epithelial cells","volume":"222","author":"Mikami","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.ymthe.2025.04.026_bib250","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.intimp.2015.10.006","article-title":"HDAC expression and activity is upregulated in diseased lupus-prone mice","volume":"29","author":"Regna","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib251","doi-asserted-by":"crossref","first-page":"28833","DOI":"10.1074\/jbc.M111.233932","article-title":"Histone deacetylase 9 deficiency protects against effector T cell-mediated systemic autoimmunity","volume":"286","author":"Yan","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2025.04.026_bib252","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1080\/0886022X.2021.1914657","article-title":"Correlation analysis between expression of histone deacetylase 6 and clinical parameters in IgA nephropathy patients","volume":"43","author":"Hu","year":"2021","journal-title":"Ren. Fail."},{"key":"10.1016\/j.ymthe.2025.04.026_bib253","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1073\/pnas.68.2.378","article-title":"Hemoglobin synthesis in murine virus-induced leukemic cells in vitro: stimulation of erythroid differentiation by dimethyl sulfoxide","volume":"68","author":"Friend","year":"1971","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.04.026_bib254","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1073\/pnas.72.3.1003","article-title":"Induction of erythroid differentiation in murine virus infected eythroleukemia cells by highly polar compounds","volume":"72","author":"Tanaka","year":"1975","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.04.026_bib255","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1073\/pnas.73.3.862","article-title":"A new group of potent inducers of differentiation in murine erythroleukemia cells","volume":"73","author":"Reuben","year":"1976","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.04.026_bib256","doi-asserted-by":"crossref","first-page":"5542","DOI":"10.1073\/pnas.88.13.5542","article-title":"Potent cytodifferentiating agents related to hexamethylenebisacetamide","volume":"88","author":"Breslow","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.04.026_bib257","doi-asserted-by":"crossref","first-page":"5705","DOI":"10.1073\/pnas.93.12.5705","article-title":"Second generation hybrid polar compounds are potent inducers of transformed cell differentiation","volume":"93","author":"Richon","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.04.026_bib258","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1073\/pnas.95.6.3003","article-title":"A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases","volume":"95","author":"Richon","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.04.026_bib259","doi-asserted-by":"crossref","first-page":"17174","DOI":"10.1016\/S0021-9258(17)44885-X","article-title":"Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A","volume":"265","author":"Yoshida","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2025.04.026_bib260","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/sj.onc.1210204","article-title":"Discovery and development of SAHA as an anticancer agent","volume":"26","author":"Marks","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.ymthe.2025.04.026_bib261","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1080\/17460441.2021.1877656","article-title":"An update on the emerging approaches for histone deacetylase (HDAC) inhibitor drug discovery and future perspectives","volume":"16","author":"Su","year":"2021","journal-title":"Expert Opin. Drug Dis."},{"key":"10.1016\/j.ymthe.2025.04.026_bib262","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101312","article-title":"HDAC inhibitors: Targets for tumor therapy, immune modulation and lung diseases","volume":"16","author":"Shanmugam","year":"2022","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib263","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/978-1-4939-3667-0_19","article-title":"HDAC Inhibitors","volume":"1436","author":"Olzscha","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib264","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175216","article-title":"The emerging roles of HDACs and their therapeutic implications in cancer","volume":"931","author":"Hai","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib265","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/bs.acr.2018.02.006","article-title":"Advances and Challenges of HDAC Inhibitors in Cancer Therapeutics","volume":"138","author":"McClure","year":"2018","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.ymthe.2025.04.026_bib266","doi-asserted-by":"crossref","first-page":"i46","DOI":"10.1136\/annrheumdis-2011-200593","article-title":"HDAC inhibitor therapy in autoimmunity and transplantation","volume":"71","author":"Hancock","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ymthe.2025.04.026_bib267","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/143269","article-title":"Targeting HDACs: a promising therapy for Alzheimer's disease","volume":"2011","author":"Xu","year":"2011","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ymthe.2025.04.026_bib268","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2174\/1570159X19666210609160017","article-title":"Understanding the Role of Histone Deacetylase and their Inhibitors in Neurodegenerative Disorders: Current Targets and Future Perspective","volume":"20","author":"Kumar","year":"2022","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib269","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/17460441.2024.2305730","article-title":"Advances in structure-activity relationships of HDAC inhibitors as HIV latency-reversing agents","volume":"19","author":"Khatun","year":"2024","journal-title":"EXPERT OPIN. DRUG DIS."},{"key":"10.1016\/j.ymthe.2025.04.026_bib270","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1021\/acsmedchemlett.1c00336","article-title":"Novel Histone Deacetylase Inhibitors for Treating HIV Infection","volume":"12","author":"Sabnis","year":"2021","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ymthe.2025.04.026_bib271","doi-asserted-by":"crossref","first-page":"F997","DOI":"10.1152\/ajprenal.00186.2017","article-title":"An inhibitor of histone deacetylase 6 activity, ACY-1215, reduces cAMP and cyst growth in polycystic kidney disease","volume":"313","author":"Yanda","year":"2017","journal-title":"AM. J. Physiol-renal"},{"key":"10.1016\/j.ymthe.2025.04.026_bib272","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.ajpath.2017.12.016","article-title":"Combination of a Histone Deacetylase 6 Inhibitor and a Somatostatin Receptor Agonist Synergistically Reduces Hepatorenal Cystogenesis in an Animal Model of Polycystic Liver Disease","volume":"188","author":"Lorenzo Pisarello","year":"2018","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib273","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3727\/096504016X14666990347635","article-title":"Ritonavir Interacts With Belinostat to Cause Endoplasmic Reticulum Stress and Histone Acetylation in Renal Cancer Cells","volume":"24","author":"Isono","year":"2016","journal-title":"Oncol. Res."},{"key":"10.1016\/j.ymthe.2025.04.026_bib274","first-page":"3161","article-title":"HDAC inhibitors synergize antiproliferative effect of sorafenib in renal cell carcinoma cells","volume":"32","author":"Kim","year":"2012","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ymthe.2025.04.026_bib275","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.juro.2014.11.091","article-title":"Combination treatment of renal cell carcinoma with belinostat and 5-fluorouracil: a role for oxidative stress induced DNA damage and HSP90 regulated thymidine synthase","volume":"193","author":"Kim","year":"2015","journal-title":"J. Urol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib276","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21041473","article-title":"CG200745, a Novel HDAC Inhibitor, Attenuates Kidney Fibrosis in a Murine Model of Alport Syndrome","volume":"21","author":"Suh","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2025.04.026_bib277","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.108681","article-title":"HDAC1\/2 inhibitor therapy improves multiple organ systems in aged mice","volume":"27","author":"Tammaro","year":"2024","journal-title":"Iscience"},{"key":"10.1016\/j.ymthe.2025.04.026_bib278","article-title":"Class I histone deacetylase inhibitor entinostat suppresses regulatory T cells and enhances immunotherapies in renal and prostate cancer models","volume":"7","author":"Shen","year":"2012","journal-title":"PLOS One"},{"key":"10.1016\/j.ymthe.2025.04.026_bib279","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.trim.2010.02.003","article-title":"Prevention of renal interstitial fibrosis via histone deacetylase inhibition in rats with unilateral ureteral obstruction","volume":"23","author":"Kinugasa","year":"2010","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib280","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12885-014-1003-1","article-title":"The novel histone deacetylase inhibitor, N-hydroxy-7-(2-naphthylthio) hepatonomide, exhibits potent antitumor activity due to cytochrome-c-release-mediated apoptosis in renal cell carcinoma cells","volume":"15","author":"Park","year":"2015","journal-title":"BMC Canc."},{"key":"10.1016\/j.ymthe.2025.04.026_bib281","doi-asserted-by":"crossref","first-page":"8814","DOI":"10.1158\/0008-5472.CAN-05-4598","article-title":"Class II histone deacetylases are associated with VHL-independent regulation of hypoxia-inducible factor 1 alpha","volume":"66","author":"Qian","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2025.04.026_bib282","first-page":"1409","article-title":"Histone deacetylase inhibitors induce human renal cell carcinoma cell apoptosis through p-JNK activation","volume":"33","author":"Xu","year":"2013","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"10.1016\/j.ymthe.2025.04.026_bib283","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1158\/1078-0432.CCR-08-1918","article-title":"Dual degradation of aurora A and B kinases by the histone deacetylase inhibitor LBH589 induces G2-M arrest and apoptosis of renal cancer cells","volume":"15","author":"Cha","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2025.04.026_bib284","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1681\/ASN.2012111055","article-title":"Histone deacetylase inhibitor enhances recovery after AKI","volume":"24","author":"Cianciolo Cosentino","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib285","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.848938","article-title":"Selective Inhibition of Histone Deacetylase Class IIa With MC1568 Ameliorates Podocyte Injury","volume":"9","author":"He","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.ymthe.2025.04.026_bib286","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1111\/jcmm.12919","article-title":"Class I HDACs specifically regulate E-cadherin expression in human renal epithelial cells","volume":"20","author":"Choi","year":"2016","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.ymthe.2025.04.026_bib287","article-title":"Blocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signaling","volume":"8","author":"Liu","year":"2013","journal-title":"PLOS One"},{"key":"10.1016\/j.ymthe.2025.04.026_bib288","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.12659\/MSM.906362","article-title":"The Nephroprotective Effect of MS-275 on Lipopolysaccharide (LPS)-Induced Acute Kidney Injury by Inhibiting Reactive Oxygen Species (ROS)-Oxidative Stress and Endoplasmic Reticulum Stress","volume":"24","author":"Zhang","year":"2018","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.ymthe.2025.04.026_bib289","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1530\/JOE-16-0322","article-title":"Sodium butyrate activates NRF2 to ameliorate diabetic nephropathy possibly via inhibition of HDAC","volume":"232","author":"Dong","year":"2017","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib290","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.fct.2014.08.010","article-title":"Sodium butyrate, a HDAC inhibitor ameliorates eNOS, iNOS and TGF-beta1-induced fibrogenesis, apoptosis and DNA damage in the kidney of juvenile diabetic rats","volume":"73","author":"Khan","year":"2014","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib291","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.4161\/cbt.4.10.2022","article-title":"Histone deacetylase inhibitors modulate renal cell carcinoma sensitivity to TRAIL\/Apo-2L-induced apoptosis by enhancing TRAIL-R2 expression","volume":"4","author":"VanOosten","year":"2005","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.ymthe.2025.04.026_bib292","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejphar.2013.03.018","article-title":"Histone deacetylase inhibitor, sodium butyrate, attenuates gentamicin-induced nephrotoxicity by increasing prohibitin protein expression in rats","volume":"707","author":"Sun","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib293","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1021\/acsptsci.1c00243","article-title":"Validation of HDAC8 Inhibitors as Drug Discovery Starting Points to Treat Acute Kidney Injury","volume":"5","author":"Long","year":"2022","journal-title":"ACS Pharmacol. Transl."},{"key":"10.1016\/j.ymthe.2025.04.026_bib294","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1042\/CS20210823","article-title":"Inhibition of HDAC3 protects against kidney cold storage\/transplantation injury and allograft dysfunction","volume":"136","author":"Xiang","year":"2022","journal-title":"Clin. Sci."},{"key":"10.1016\/j.ymthe.2025.04.026_bib295","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.phrs.2019.02.011","article-title":"Inhibition of class I HDACs attenuates renal interstitial fibrosis in a murine model","volume":"142","author":"Yang","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ymthe.2025.04.026_bib296","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/ki.2015.326","article-title":"Histone deacetylase-mediated silencing of AMWAP expression contributes to cisplatin nephrotoxicity","volume":"89","author":"Ranganathan","year":"2016","journal-title":"Kidney Int."},{"key":"10.1016\/j.ymthe.2025.04.026_bib297","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.kint.2015.12.010","article-title":"Upregulation of AMWAP: a novel mechanism for HDAC inhibitors to protect against cisplatin nephrotoxicity","volume":"89","author":"Tang","year":"2016","journal-title":"Kidney Int."},{"key":"10.1016\/j.ymthe.2025.04.026_bib298","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.918528","article-title":"Romidepsin (FK228) in a Mouse Model of Lipopolysaccharide-Induced Acute Kidney Injury is Associated with Down-Regulation of the CYP2E1 Gene","volume":"26","author":"Cheng","year":"2020","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.ymthe.2025.04.026_bib299","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.intimp.2016.11.008","article-title":"Therapeutic activity of the histone deacetylase inhibitor SB939 on renal fibrosis","volume":"42","author":"Kang","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib300","doi-asserted-by":"crossref","first-page":"F1015","DOI":"10.1152\/ajprenal.00405.2020","article-title":"Class IIa HDAC inhibitor TMP195 alleviates lipopolysaccharide-induced acute kidney injury","volume":"319","author":"Zhang","year":"2020","journal-title":"AM. J. Physiol-renal"},{"key":"10.1016\/j.ymthe.2025.04.026_bib301","article-title":"Histone deacetylase inhibitor, CG200745 attenuates renal fibrosis in obstructive kidney disease","volume":"8","author":"Choi","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2025.04.026_bib302","doi-asserted-by":"crossref","first-page":"F133","DOI":"10.1152\/ajprenal.00400.2009","article-title":"Histone deacetylase modulates the proinflammatory and -fibrotic changes in tubulointerstitial injury","volume":"298","author":"Marumo","year":"2010","journal-title":"AM. J. Physiol-renal"},{"key":"10.1016\/j.ymthe.2025.04.026_bib303","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21175966","article-title":"Trichostatin A Alleviates Renal Interstitial Fibrosis Through Modulation of the M2 Macrophage Subpopulation","volume":"21","author":"Tseng","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2025.04.026_bib304","doi-asserted-by":"crossref","first-page":"F996","DOI":"10.1152\/ajprenal.00282.2009","article-title":"Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy","volume":"297","author":"Pang","year":"2009","journal-title":"AM. J. Physiol-renal"},{"key":"10.1016\/j.ymthe.2025.04.026_bib305","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.juro.2013.06.110","article-title":"HDAC dependent transcriptional repression of Bmp-7 potentiates TGF-beta mediated renal fibrosis in obstructive uropathy","volume":"191","author":"Manson","year":"2014","journal-title":"J. Urol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib306","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/ajt.13106","article-title":"Class-specific histone\/protein deacetylase inhibition protects against renal ischemia reperfusion injury and fibrosis formation","volume":"15","author":"Levine","year":"2015","journal-title":"Am. J. Transpl."},{"key":"10.1016\/j.ymthe.2025.04.026_bib307","doi-asserted-by":"crossref","first-page":"F875","DOI":"10.1152\/ajprenal.00499.2018","article-title":"Dynamic changes in histone deacetylases following kidney ischemia-reperfusion injury are critical for promoting proximal tubule proliferation","volume":"316","author":"Hyndman","year":"2019","journal-title":"AM. J. Physiol-renal"},{"key":"10.1016\/j.ymthe.2025.04.026_bib308","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2020.101330","article-title":"Treg expansion with trichostatin A ameliorates kidney ischemia\/reperfusion injury in mice by suppressing the expression of costimulatory molecules","volume":"63","author":"Yamamoto","year":"2020","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib309","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/s41419-018-0374-7","article-title":"Histone deacetylase inhibitors protect against cisplatin-induced acute kidney injury by activating autophagy in proximal tubular cells","volume":"9","author":"Liu","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ymthe.2025.04.026_bib310","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/s41419-020-03267-2","article-title":"PSTPIP2 inhibits cisplatin-induced acute kidney injury by suppressing apoptosis of renal tubular epithelial cells","volume":"11","author":"Zhu","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ymthe.2025.04.026_bib311","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1124\/jpet.108.137398","article-title":"Induction of apoptosis in renal tubular cells by histone deacetylase inhibitors, a family of anticancer agents","volume":"325","author":"Dong","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ymthe.2025.04.026_bib312","doi-asserted-by":"crossref","first-page":"F293","DOI":"10.1152\/ajprenal.00410.2009","article-title":"Inhibitors of histone deacetylases suppress cisplatin-induced p53 activation and apoptosis in renal tubular cells","volume":"298","author":"Dong","year":"2010","journal-title":"AM. J. Physiol-renal"},{"key":"10.1016\/j.ymthe.2025.04.026_bib313","first-page":"1129","article-title":"Trichostatin inhibits the growth of ACHN renal cell carcinoma cells via cell cycle arrest in association with p27, or apoptosis","volume":"22","author":"Park","year":"2003","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib314","first-page":"384","article-title":"[Histone Deacetylation Down-regulates the Expression of BNIP3 in Renal Cell Carcinoma]","volume":"48","author":"Liu","year":"2017","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.ymthe.2025.04.026_bib315","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ejphar.2019.01.040","article-title":"Trichostatin A modulates cellular metabolism in renal cell carcinoma to enhance sunitinib sensitivity","volume":"847","author":"Sato","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib316","doi-asserted-by":"crossref","first-page":"F577","DOI":"10.1152\/ajprenal.00487.2007","article-title":"Restoration of CREB function ameliorates cisplatin cytotoxicity in renal tubular cells","volume":"294","author":"Arany","year":"2008","journal-title":"AM. J. Physiol-renal"},{"key":"10.1016\/j.ymthe.2025.04.026_bib317","doi-asserted-by":"crossref","first-page":"F426","DOI":"10.1152\/ajprenal.00107.2009","article-title":"Effects of histone deacetylase inhibitors on rat mesangial cells","volume":"298","author":"Freidkin","year":"2010","journal-title":"AM. J. Physiol-renal"},{"key":"10.1016\/j.ymthe.2025.04.026_bib318","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1172\/JCI16153","article-title":"Histone deacetylase inhibitors modulate renal disease in the MRL-lpr\/lpr mouse","volume":"111","author":"Mishra","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2025.04.026_bib363","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1681\/ASN.2014020129","article-title":"Epigenetic regulation of microRNAs controlling CLDN14 expression as a mechanism for renal calcium handling","volume":"26","author":"Gong","year":"2015","journal-title":"JASN"},{"key":"10.1016\/j.ymthe.2025.04.026_bib319","doi-asserted-by":"crossref","first-page":"12497","DOI":"10.1074\/jbc.M114.635540","article-title":"Acetylation stimulates the epithelial sodium channel by reducing its ubiquitination and degradation","volume":"290","author":"Butler","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2025.04.026_bib320","first-page":"398","article-title":"Protective role and mechanism of tubastatin A on renal and intestinal injuries after cardiopulmonary resuscitation in swine","volume":"35","author":"Wu","year":"2023","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"10.1016\/j.ymthe.2025.04.026_bib321","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fphar.2018.00034","article-title":"HDAC6 Inhibition Promotes Transcription Factor EB Activation and Is Protective in Experimental Kidney Disease","volume":"9","author":"Brijmohan","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib322","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3892\/mmr.2015.4580","article-title":"Valproate attenuates diabetic nephropathy through inhibition of endoplasmic reticulum stress-induced apoptosis","volume":"13","author":"Sun","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ymthe.2025.04.026_bib323","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biochi.2014.12.015","article-title":"Valproate attenuates the proteinuria, podocyte and renal injury by facilitating autophagy and inactivation of NF-kappaB\/iNOS signaling in diabetic rat","volume":"110","author":"Khan","year":"2015","journal-title":"BIOCHIMIE"},{"key":"10.1016\/j.ymthe.2025.04.026_bib324","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.yexmp.2015.01.003","article-title":"Sodium valproate ameliorates diabetes-induced fibrosis and renal damage by the inhibition of histone deacetylases in diabetic rat","volume":"98","author":"Khan","year":"2015","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib325","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jss.2014.05.030","article-title":"Valproic acid protects septic mice from renal injury by reducing the inflammatory response","volume":"192","author":"Zheng","year":"2014","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.ymthe.2025.04.026_bib326","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5985903","article-title":"Valproic Acid Prevents Renal Dysfunction and Inflammation in the Ischemia-Reperfusion Injury Model","volume":"2016","author":"Costalonga","year":"2016","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.ymthe.2025.04.026_bib327","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1111\/j.1582-4934.2008.00436.x","article-title":"The histone deacetylase inhibitor valproic acid alters growth properties of renal cell carcinoma in vitro and in vivo","volume":"13","author":"Jones","year":"2009","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.ymthe.2025.04.026_bib328","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s11033-013-2996-2","article-title":"VPA inhibits renal cancer cell migration by targeting HDAC2 and down-regulating HIF-1alpha","volume":"41","author":"Yang","year":"2014","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.ymthe.2025.04.026_bib329","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1464-410X.2009.08759.x","article-title":"Effects of combined valproic acid and the epidermal growth factor\/vascular endothelial growth factor receptor tyrosine kinase inhibitor AEE788 on renal cell carcinoma cell lines in vitro","volume":"105","author":"Juengel","year":"2010","journal-title":"BJU Int."},{"key":"10.1016\/j.ymthe.2025.04.026_bib330","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.canlet.2012.05.003","article-title":"Acetylation of histone H3 prevents resistance development caused by chronic mTOR inhibition in renal cell carcinoma cells","volume":"324","author":"Juengel","year":"2012","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ymthe.2025.04.026_bib331","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.taap.2013.05.013","article-title":"Comparison of trichostatin A and valproic acid treatment regimens in a mouse model of kidney fibrosis","volume":"271","author":"Van Beneden","year":"2013","journal-title":"Toxicol. Appl. Pharm."},{"key":"10.1016\/j.ymthe.2025.04.026_bib332","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1681\/ASN.2010111196","article-title":"Valproic acid attenuates proteinuria and kidney injury","volume":"22","author":"Van Beneden","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib333","first-page":"95","article-title":"Inhibition of histone deacetylase 1 ameliorates renal tubulointerstitial fibrosis via modulation of inflammation and extracellular matrix gene transcription in mice","volume":"41","author":"Nguyen-Thanh","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ymthe.2025.04.026_bib334","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2217\/epi-2016-0034","article-title":"Anti-fibrotic effects of valproic acid: role of HDAC inhibition and associated mechanisms","volume":"8","author":"Khan","year":"2016","journal-title":"Epigenomics"},{"key":"10.1016\/j.ymthe.2025.04.026_bib335","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1681\/ASN.2015091004","article-title":"Deletion of ADP Ribosylation Factor-Like GTPase 13B Leads to Kidney Cysts","volume":"27","author":"Li","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib336","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/cas.14225","article-title":"Fluvastatin potentiates anticancer activity of vorinostat in renal cancer cells","volume":"111","author":"Okubo","year":"2020","journal-title":"Cancer Sci."},{"key":"10.1016\/j.ymthe.2025.04.026_bib337","doi-asserted-by":"crossref","DOI":"10.1016\/j.urology.2010.04.042","article-title":"Combination of suberoylanilide hydroxamic acid and ritonavir is effective against renal cancer cells","volume":"76","author":"Sato","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.ymthe.2025.04.026_bib338","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.4161\/cbt.7.10.6584","article-title":"Gene microarray analysis of human renal cell carcinoma: the effects of HDAC inhibition and retinoid treatment","volume":"7","author":"Tavares","year":"2008","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.ymthe.2025.04.026_bib339","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/bjc.2017.33","article-title":"Combination of the histone deacetylase inhibitor vorinostat with bevacizumab in patients with clear-cell renal cell carcinoma: a multicentre, single-arm phase I\/II clinical trial","volume":"116","author":"Pili","year":"2017","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ymthe.2025.04.026_bib340","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1016\/j.ajpath.2011.01.044","article-title":"Long-term administration of the histone deacetylase inhibitor vorinostat attenuates renal injury in experimental diabetes through an endothelial nitric oxide synthase-dependent mechanism","volume":"178","author":"Advani","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib341","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1038\/ki.2011.39","article-title":"Histone deacetylase inhibition attenuates diabetes-associated kidney growth: potential role for epigenetic modification of the epidermal growth factor receptor","volume":"79","author":"Gilbert","year":"2011","journal-title":"Kidney Int."},{"key":"10.1016\/j.ymthe.2025.04.026_bib342","first-page":"9","article-title":"Effect of histone deacetylase inhibitor (vorinostat) on new-onset diabetes induced by tacrolimus","volume":"18","author":"Bakhdar","year":"2023","journal-title":"J. Taibah Univ. Med. Sc"},{"key":"10.1016\/j.ymthe.2025.04.026_bib343","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.3892\/mmr.2015.3964","article-title":"Vorinostat protects against calcium oxalate-induced kidney injury in mice","volume":"12","author":"Wang","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ymthe.2025.04.026_bib344","doi-asserted-by":"crossref","first-page":"F496","DOI":"10.1152\/ajprenal.00534.2013","article-title":"A PTBA small molecule enhances recovery and reduces postinjury fibrosis after aristolochic acid-induced kidney injury","volume":"306","author":"Novitskaya","year":"2014","journal-title":"AM. J. Physiol-renal"},{"key":"10.1016\/j.ymthe.2025.04.026_bib345","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1471-2490-14-71","article-title":"Panobinostat synergizes with bortezomib to induce endoplasmic reticulum stress and ubiquitinated protein accumulation in renal cancer cells","volume":"14","author":"Sato","year":"2014","journal-title":"BMC Urol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib346","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-35602-1","article-title":"CKD-506, a novel HDAC6-selective inhibitor, improves renal outcomes and survival in a mouse model of systemic lupus erythematosus","volume":"8","author":"Choi","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2025.04.026_bib347","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1634\/theoncologist.12-10-1247","article-title":"FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma","volume":"12","author":"Mann","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/j.ymthe.2025.04.026_bib348","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1111\/bcp.14889","article-title":"Recent developments of HDAC inhibitors: Emerging indications and novel molecules","volume":"87","author":"Bondarev","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib349","first-page":"7412","article-title":"Vorinostat as potential antiparasitic drug","volume":"24","author":"Herrera-Martinez","year":"2020","journal-title":"Eur. Rev. Med. Pharmaco."},{"key":"10.1016\/j.ymthe.2025.04.026_bib350","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4103\/abr.abr_142_19","article-title":"Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers","volume":"8","author":"Sanaei","year":"2019","journal-title":"Adv. Biomed. Res."},{"key":"10.1016\/j.ymthe.2025.04.026_bib351","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/13543776.2020.1725470","article-title":"Histone deacetylase (HDAC) inhibitors in cancer: a patent review (2017-present)","volume":"30","author":"Zhao","year":"2020","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ymthe.2025.04.026_bib352","doi-asserted-by":"crossref","first-page":"419","DOI":"10.4103\/0019-5154.160511","article-title":"Vorinostat-An Overview","volume":"60","author":"Bubna","year":"2015","journal-title":"Indian J. Dermatol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib353","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1158\/1078-0432.CCR-20-1215","article-title":"Safety and Efficacy of Vorinostat Plus Sirolimus or Everolimus in Patients with Relapsed Refractory Hodgkin Lymphoma","volume":"26","author":"Janku","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2025.04.026_bib354","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1007\/s10637-020-01038-6","article-title":"Phase II study of the histone deacetylase inhibitor vorinostat (Suberoylanilide Hydroxamic Acid; SAHA) in recurrent or metastatic transitional cell carcinoma of the urothelium - an NCI-CTEP sponsored: California Cancer Consortium trial, NCI 6879","volume":"39","author":"Quinn","year":"2021","journal-title":"Invest. New Drug"},{"key":"10.1016\/j.ymthe.2025.04.026_bib355","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ijpddr.2020.12.003","article-title":"HDAC inhibitors Tubastatin A and SAHA affect parasite cell division and are potential anti-Toxoplasma gondii chemotherapeutics","volume":"15","author":"Araujo-Silva","year":"2021","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.ymthe.2025.04.026_bib356","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2174\/1570162X19666210118151249","article-title":"Resveratrol Promotes HIV-1 Tat Accumulation via AKT\/FOXO1 Signaling Axis and Potentiates Vorinostat to Antagonize HIV-1 Latency","volume":"19","author":"Feng","year":"2021","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.ymthe.2025.04.026_bib357","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s12017-021-08660-4","article-title":"Repurposing Vorinostat for the Treatment of Disorders Affecting Brain","volume":"23","author":"Athira","year":"2021","journal-title":"Neuromol. Med."},{"key":"10.1016\/j.ymthe.2025.04.026_bib358","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1200\/JCO.2005.16.600","article-title":"Epigenetic and chromatin modifiers as targeted therapy of hematologic malignancies","volume":"23","author":"Bhalla","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib359","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nbt1272","article-title":"Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug","volume":"25","author":"Marks","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib360","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.1038\/sj.onc.1210620","article-title":"Histone deacetylase inhibitors: molecular mechanisms of action","volume":"26","author":"Xu","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.ymthe.2025.04.026_bib361","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1007\/s00467-012-2320-8","article-title":"HDAC inhibitors in kidney development and disease","volume":"28","author":"Brilli","year":"2013","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib362","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1007\/s10637-015-0261-3","article-title":"Phase I study of the mTOR inhibitor ridaforolimus and the HDAC inhibitor vorinostat in advanced renal cell carcinoma and other solid tumors","volume":"33","author":"Zibelman","year":"2015","journal-title":"Invest. New Drug"},{"key":"10.1016\/j.ymthe.2025.04.026_bib364","article-title":"Histone deacetylase inhibitor, trichostatin A, synergistically enhances paclitaxel-induced cytotoxicity in urothelial carcinoma cells by suppressing the ERK pathway","author":"Hsu","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2025.04.026_bib365","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1093\/abbs\/gmw067","article-title":"PU.1-Bim axis is involved in Trichostatin A-induced apoptosis in murine pro-B lymphoma FL5.12 cells","volume":"48","author":"Li","year":"2016","journal-title":"Acta Bioch. Bioph. Sin."},{"key":"10.1016\/j.ymthe.2025.04.026_bib366","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1038\/s41388-020-01636-x","article-title":"HDAC inhibition potentiates anti-tumor activity of macrophages and enhances anti-PD-L1-mediated tumor suppression","volume":"40","author":"Li","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.ymthe.2025.04.026_bib367","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/j.asjsur.2022.01.018","article-title":"Effects of trichostatin A on the apoptosis-related genes and protein expressions in the cell lines of laryngeal squamous cell carcinoma","volume":"45","author":"Zhang","year":"2022","journal-title":"Asian J. Surg."},{"key":"10.1016\/j.ymthe.2025.04.026_bib368","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.3892\/mmr.2015.3268","article-title":"Trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and promotes apoptosis of esophageal squamous cell lines","volume":"11","author":"Ma","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ymthe.2025.04.026_bib369","article-title":"Pharmacological Properties of Trichostatin A, Focusing on the Anticancer Potential: A Comprehensive Review","volume":"15","author":"Bouyahya","year":"2022","journal-title":"Pharmaceuticals-Base"},{"key":"10.1016\/j.ymthe.2025.04.026_bib370","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/21505594.2015.1049807","article-title":"Histone deacetylases: Targets for antifungal drug development","volume":"6","author":"Kmetzsch","year":"2015","journal-title":"Virulence"},{"key":"10.1016\/j.ymthe.2025.04.026_bib371","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1634\/stemcells.2007-0049","article-title":"Inhibition of histone deacetylase activates side population cells in kidney and partially reverses chronic renal injury","volume":"25","author":"Imai","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.ymthe.2025.04.026_bib372","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1002\/jcb.23135","article-title":"Histone deacetylase 1\/2 mediates proliferation of renal interstitial fibroblasts and expression of cell cycle proteins","volume":"112","author":"Pang","year":"2011","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ymthe.2025.04.026_bib373","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1681\/ASN.2005111187","article-title":"Inhibition of histone deacetylase activity suppresses epithelial-to-mesenchymal transition induced by TGF-beta1 in human renal epithelial cells","volume":"18","author":"Yoshikawa","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib374","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1080\/01612840.2022.2122431","article-title":"Versatile Valproic Acid","volume":"43","author":"Woolley","year":"2022","journal-title":"Issues Ment. Health N."},{"key":"10.1016\/j.ymthe.2025.04.026_bib375","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27010104","article-title":"Insights into Structural Modifications of Valproic Acid and Their Pharmacological Profile","volume":"27","author":"Mishra","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ymthe.2025.04.026_bib376","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/npr2.12196","article-title":"Neuropharmacology of Antiseizure Drugs","volume":"41","author":"Hakami","year":"2021","journal-title":"Neuropsychopharmacol. Rep."},{"key":"10.1016\/j.ymthe.2025.04.026_bib377","first-page":"347","article-title":"Medical Treatment of Epilepsy","volume":"75","author":"Jin","year":"2023","journal-title":"Brain Nerve"},{"key":"10.1016\/j.ymthe.2025.04.026_bib378","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112021","article-title":"Hidden pharmacological activities of valproic acid: A new insight","volume":"142","author":"Singh","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ymthe.2025.04.026_bib379","doi-asserted-by":"crossref","first-page":"10842","DOI":"10.1021\/ja102758v","article-title":"Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A","volume":"132","author":"Butler","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ymthe.2025.04.026_bib380","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejop.2021.125821","article-title":"Tubastatin A, a deacetylase inhibitor, as a tool to study the division, cell cycle and microtubule cytoskeleton of trypanosomatids","volume":"80","author":"de Oliveira Santos","year":"2021","journal-title":"Eur. J. Protistol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib381","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102677","article-title":"Tubastatin A potently inhibits GPX4 activity to potentiate cancer radiotherapy through boosting ferroptosis","volume":"62","author":"Liu","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib382","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111921","article-title":"Pharmacological blockade of HDAC6 attenuates cancer progression by inhibiting IL-1beta and modulating immunosuppressive response in OSCC","volume":"132","author":"Mahale","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib383","doi-asserted-by":"crossref","first-page":"16533","DOI":"10.1021\/acs.jmedchem.4c01367","article-title":"Contilisant+Tubastatin A Hybrids: Polyfunctionalized Indole Derivatives as New HDAC Inhibitor-Based Multitarget Small Molecules with In Vitro and In Vivo Activity in Neurodegenerative Diseases","volume":"67","author":"Toledano-Pinedo","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ymthe.2025.04.026_bib384","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ejmech.2019.01.077","article-title":"Histone deacetylase 3 inhibitors in learning and memory processes with special emphasis on benzamides","volume":"166","author":"Amin","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ymthe.2025.04.026_bib385","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1177\/1535370220928278","article-title":"Histone deacetylase-3: Friend and foe of the brain","volume":"245","author":"D'Mello","year":"2020","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.ymthe.2025.04.026_bib386","doi-asserted-by":"crossref","first-page":"13124","DOI":"10.1523\/JNEUROSCI.0914-15.2015","article-title":"Histone Deacetylase Inhibition via RGFP966 Releases the Brakes on Sensory Cortical Plasticity and the Specificity of Memory Formation","volume":"35","author":"Bieszczad","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ymthe.2025.04.026_bib387","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1021\/acschemneuro.1c00826","article-title":"HDAC3 Inhibitor RGFP966 Ameliorated Neuroinflammation in the Cuprizone-Induced Demyelinating Mouse Model and LPS-Stimulated BV2 Cells by Downregulating the P2X7R\/STAT3\/NF-kappaB65\/NLRP3 Activation","volume":"13","author":"Sun","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ymthe.2025.04.026_bib388","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s12035-022-03083-z","article-title":"Histone Deacetylase 3 Inhibition Decreases Cerebral Edema and Protects the Blood-Brain Barrier After Stroke","volume":"60","author":"Lu","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib389","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1038\/npp.2015.93","article-title":"Pharmacological Selectivity Within Class I Histone Deacetylases Predicts Effects on Synaptic Function and Memory Rescue","volume":"40","author":"Rumbaugh","year":"2015","journal-title":"Neuropsychopharmacol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib390","first-page":"57","article-title":"A phase II study of depsipeptide in refractory metastatic renal cell cancer","volume":"5","author":"Stadler","year":"2006","journal-title":"Clin. Genitourin. Canc."},{"key":"10.1016\/j.ymthe.2025.04.026_bib391","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3109\/07357907.2011.590568","article-title":"A phase II trial of panobinostat, a histone deacetylase inhibitor, in the treatment of patients with refractory metastatic renal cell carcinoma","volume":"29","author":"Hainsworth","year":"2011","journal-title":"Cancer Invest."},{"key":"10.1016\/j.ymthe.2025.04.026_bib392","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/bjc.2011.527","article-title":"Phase I study of the histone deacetylase inhibitor entinostat in combination with 13-cis retinoic acid in patients with solid tumours","volume":"106","author":"Pili","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ymthe.2025.04.026_bib393","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10637-012-9812-z","article-title":"A phase I study of sorafenib and vorinostat in patients with advanced solid tumors with expanded cohorts in renal cell carcinoma and non-small cell lung cancer","volume":"31","author":"Dasari","year":"2013","journal-title":"Invest. New Drug"},{"key":"10.1016\/j.ymthe.2025.04.026_bib394","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1007\/s10637-019-00864-7","article-title":"Phase I study of the mTOR inhibitor everolimus in combination with the histone deacetylase inhibitor panobinostat in patients with advanced clear cell renal cell carcinoma","volume":"38","author":"Wood","year":"2020","journal-title":"Invest. New Drug"},{"key":"10.1016\/j.ymthe.2025.04.026_bib395","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s10637-019-00880-7","article-title":"NCI 6896: a phase I trial of vorinostat (SAHA) and isotretinoin (13-cis retinoic acid) in the treatment of patients with advanced renal cell carcinoma","volume":"38","author":"Molina","year":"2020","journal-title":"Invest. New Drug"},{"key":"10.1016\/j.ymthe.2025.04.026_bib396","doi-asserted-by":"crossref","first-page":"7199","DOI":"10.1158\/1078-0432.CCR-17-1178","article-title":"Immunomodulation by Entinostat in Renal Cell Carcinoma Patients Receiving High-Dose Interleukin 2: A Multicenter, Single-Arm, Phase I\/II Trial (NCI-CTEP#7870)","volume":"23","author":"Pili","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2025.04.026_bib397","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2174\/187231207780363642","article-title":"Disposition of vorinostat, a novel histone deacetylase inhibitor and anticancer agent, in preclinical species","volume":"1","author":"Sandhu","year":"2007","journal-title":"Drug Metab. Lett."},{"key":"10.1016\/j.ymthe.2025.04.026_bib398","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1080\/00498254.2016.1184356","article-title":"Clinical pharmacokinetics of panobinostat, a novel histone deacetylase (HDAC) inhibitor: review and perspectives","volume":"47","author":"Srinivas","year":"2017","journal-title":"Xenobiotica."},{"key":"10.1016\/j.ymthe.2025.04.026_bib399","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1007\/s00277-024-05691-2","article-title":"A real-world pharmacovigilance study investigating the toxicities of histone deacetylase inhibitors","volume":"103","author":"Li","year":"2024","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.ymthe.2025.04.026_bib400","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112831","article-title":"Recent progress on HDAC inhibitors with dual targeting capabilities for cancer treatment","volume":"208","author":"Peng","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ymthe.2025.04.026_bib401","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053100","article-title":"Resistance after chronic application of the HDAC-inhibitor valproic acid is associated with elevated Akt activation in renal cell carcinoma in vivo","volume":"8","author":"Juengel","year":"2013","journal-title":"PLOS One"},{"key":"10.1016\/j.ymthe.2025.04.026_bib402","article-title":"Nano-based drug delivery system for therapeutics: a comprehensive review","volume":"9","author":"Prakash","year":"2023","journal-title":"Biomed. Phys. Eng. Expr."},{"key":"10.1016\/j.ymthe.2025.04.026_bib403","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.2174\/1567201818666210609161301","article-title":"Targeted Drug Delivery: Trends and Perspectives","volume":"18","author":"Ashique","year":"2021","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.ymthe.2025.04.026_bib404","doi-asserted-by":"crossref","first-page":"8977","DOI":"10.1021\/acs.jmedchem.0c00491","article-title":"Dual-Target Inhibitors Based on HDACs: Novel Antitumor Agents for Cancer Therapy","volume":"63","author":"Liu","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ymthe.2025.04.026_bib405","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.2174\/0929867329666220922105615","article-title":"Multi-targeted HDAC Inhibitors as Anticancer Agents: Current Status and Future Prospective","volume":"30","author":"Patel","year":"2023","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ymthe.2025.04.026_bib406","doi-asserted-by":"crossref","first-page":"7264","DOI":"10.2174\/0929867327666200102115720","article-title":"Recent Advances in Multi-target Drugs Targeting Protein Kinases and Histone Deacetylases in Cancer Therapy","volume":"27","author":"Ling","year":"2020","journal-title":"Curr. Med. Chem."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625003004?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625003004?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T13:42:25Z","timestamp":1786023745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001625003004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":405,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1525001625003004"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.04.026","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histone deacetylases and their inhibitors in kidney diseases","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.04.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The American Society of Gene and Cell Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}